| Dr Robert Cleaveland Moore, MD | |
|
600 Ridgely Ave, Suite222, Annapolis, MD 21401-1001 | |
| (410) 266-5084 | |
| (410) 266-7289 |
| Full Name | Dr Robert Cleaveland Moore |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 600 Ridgely Ave, Annapolis, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033151964 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | D25178 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Cleaveland Moore, MD 600 Ridgely Ave, Suite222, Annapolis, MD 21401-1001 Ph: (410) 266-5084 | Dr Robert Cleaveland Moore, MD 600 Ridgely Ave, Suite222, Annapolis, MD 21401-1001 Ph: (410) 266-5084 |
News Archive
The prevalence of benign thyroid nodules is high and there are certain ultrasound features, suggesting malignancy, that can help radiologists determine whether or not a biopsy is needed, according to a study performed at the University of California San Francisco Medical Center, San Francisco, CA.
Consumer Reports and ConsumerReportsHealth.org cover issues pertaining to the efficacy and safety of prescription and non-prescription drugs (including natural medicines), mental health, diet and nutrition, food safety, and fitness.
Senate Majority Leader Sen. Harry Reid's health reform bill fulfills the promise that more than 132 million Americans with family dental coverage can keep their current dental plan without disrupting established dentist-patient relationships, according to the National Association of Dental Plans.
Van Andel Research Institute (VARI) scientists have determined how two proteins required for the initiation and development of prostate cancer interact at the molecular level, which could lead to improved treatments for the disease.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program) to fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Alpha 1 Antitrypsin Deficiency (AAT), a genetic disease known to result in serious lung and/or liver disease.
› Verified 8 days ago
Dr. David E Matteson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-1000 Fax: 443-481-1360 | |
Craig J Schaefer, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 2001 Medical Pkwy, Acute Care Pavilion, Annapolis, MD 21401 Phone: 443-481-1000 Fax: 443-481-1360 | |
Dr. Steven L Quigley, MD Surgery Medicare: Medicare Enrolled Practice Location: 2001 Medical Parkway, Annapolis, MD 21401 Phone: 443-481-1000 Fax: 443-481-1360 | |
Dr. Wen Chi Liang, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 200, Annapolis, MD 21401 Phone: 443-481-5300 Fax: 443-481-6705 | |
Patrick P. Schimpf, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 410-604-0005 | |
Meghan L. Milburn, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-5300 Fax: 443-481-6705 |